In this article we present the list of top 10 large-cap healthcare stocks to buy now. Click to skip ahead and see the Top 5 Large-Cap Healthcare Stocks...
Keep Reading →
February 6 - Hedge Fund Analysis, Hedge Funds, News - Comments
In this article we’ll check out the Top 5 Stocks Warren Buffett Just Bought. For more background on the Oracle of Omaha and some of his other top stock...
Keep Reading →
November 27 - Hedge Fund Analysis, Hedge Funds, News - Comments
Meet The Hedge Fund Manager Who Thinks Math Is Overrated (When It Comes To Investing) (Forbes) Eric Chung, chief investment officer of Lighthaven Capital...
Keep Reading →
August 10 - Hedge Funds, Insider Trading - Comments
Steve Cohen’s Venture Firm Invests in U.S. Cybersecurity Company (Reuters) NEW YORK (Reuters) – Billionaire investor Steve Cohen’s Point72...
Keep Reading →
February 20 - Hedge Funds, Insider Trading - Comments
Billionaire Dan Loeb, the founder of $18 billion hedge fund Third Point, is mired in a fourth-straight year of trailing the market, though the activist...
Keep Reading →
December 20 - Hedge Fund Analysis, Hedge Funds, News - Comments
Fisher Investments was founded in 1979 by billionaire Ken Fisher. The fee-only investment adviser managed more than $100 billion in assets as of July...
Keep Reading →
November 13 - Dividend Stocks, Hedge Funds, News - Comments
Billionaire’s Trump Impeachment Push Grows in Midterm Run-Up (Fox News) Liberal billionaire Tom Steyer claims to be building a juggernaut political...
Keep Reading →
October 19 - Hedge Funds, Insider Trading - Comments
Andreas Halvorsen Discloses Stake In Urovant Sciences (Forbes.com) Andreas Halvorsen’s Viking Global Investors disclosed Thursday that it holds a 75...
Keep Reading →
October 12 - Hedge Funds, Insider Trading - Comments
Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk has made amends with investors of his company after a poorly handled earnings call last week sent shares...
Keep Reading →
May 8 - Insider Trading, News, Tech - Comments
Merck & Co., Inc. (NYSE:MRK) (Ticker.tv) On Tuesday before the market opened, shares of Merck & Co ($MRK) were gapping up on news of positive...
Keep Reading →
January 16 - Market Movers, News - Comments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr. Rosenwald...
Keep Reading →
August 25 - Hedge Funds, News - Comments
If you’re seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the...
Keep Reading →
July 6 - News - Comments
Healthcare is a vast sector that nonetheless has huge growth prospects, with the U.S government and its citizens spending about $3 trillion annually...
Keep Reading →
May 3 - Hedge Funds, News - Comments
Merck & Co. Inc. (NYSE:MRK) entered the markets on April 7 in green, amid a thumbs down from the U.S. Food and Drug Administration on its request...
Keep Reading →
April 7 - News - Comments
Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc. (NYSE:MRK) claiming that its shingles vaccine, Zostavax...
Keep Reading →
March 16 - News, Stock Analysis - Comments
The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE...
Keep Reading →
March 8 - News, Stock Analysis - Comments
Merck & Co., Inc. (NYSE:MRK) has announced that it will be writing down approximately $2.9 billion following the shrinking of the market for a hepatitis...
Keep Reading →
February 24 - News, Stock Analysis - Comments
By Khojinur Usmonov From low costs to expedited drug approval, President Trump recently met with big pharma CEOs about overhauling the entire system....
Keep Reading →
February 23 - News, Stock Analysis - Comments
Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years. Pharmaceutical firms such as Bristol-Myers...
Keep Reading →
February 21 - News, Stock Analysis - Comments
Patients with bladder cancer now having something to smile about, after the acceptance of 2 new supplemental biologics license applications, by the FDA...
Keep Reading →
February 7 - News, Stock Analysis - Comments
The European Commission has approved KEYTRUDA® (pembrolizumab), an anti-PD-1 therapy from Merck & Co., Inc. (NYSE:MRK). The Committee for Medicinal...
Keep Reading →
February 1 - News, Stock Analysis - Comments
United States President Donald Trump is urging US drugmakers to consider manufacturing more of their drugs in the United States, thinking that higher...
Keep Reading →
February 1 - News, Stock Analysis - Comments
Merck & Co., Inc. (NYSE:MRK) is one of the pharma industry titans that are currently on the receiving end as a result of exaggerated drug price hikes...
Keep Reading →
January 30 - News, Stock Analysis - Comments
Merck & Co., Inc. (NYSE:MRK) has agreed to share a portion of Keytruda sales with Bristol-Myers Squibb Co (NYSE:BMY) and Ono Pharmaceutical Co., Ltd...
Keep Reading →
January 24 - News, Stock Analysis - Comments
Palantir Technologies Inc and Merck & Co., Inc. (NYSE:MRK) German parent Merck KGaA have entered into a deal that will see them work together on a...
Keep Reading →
January 18 - News, Stock Analysis - Comments
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and...
Keep Reading →
January 17 - Lists, News - Comments
Merck & Co., Inc. (NYSE:MRK), which is popularly known as MSD outside the United States and Canada, has become part of the Oncology Research Information...
Keep Reading →
January 6 - News, Stock Analysis - Comments
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros. Ranked 128th on Forbes’ list of the richest people...
Keep Reading →
December 23 - Dividend Stocks, Hedge Funds, News - Comments
Individual lung cancer patients may soon be able to benefit from Keytruda, an immunotherapy drug from Merck & Co., Inc. (NYSE:MRK). The news comes...
Keep Reading →
December 2 - News, Stock Analysis - Comments
The Dow Jones Industrial Average (DJIA) comprises of 30 companies representing a diverse collection of stocks from all market sectors. These large cap...
Keep Reading →
November 30 - Hedge Funds, News - Comments
Stanley Druckenmiller is an American hedge fund manager who ran the $12 billion Duquesne Capital till 2010. Forbes has ranked him 128 on the list of the...
Keep Reading →
November 21 - Hedge Funds, News - Comments
OpGen Inc (NASDAQ:OPGN), a Market Exclusive favorite, earlier this week announced that it is bolstering its already long-standing relationship with pharmaceutical...
Keep Reading →
November 17 - News, Stock Analysis - Comments
Adage Capital Management is a Boston-based hedge fund founded in 2001 by Phil Gross and Robert Atchinson. As of June 30, Adage’s public equity portfolio...
Keep Reading →
November 15 - Hedge Fund Analysis, Hedge Funds, News - Comments
Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109...
Keep Reading →
November 8 - Hedge Fund Analysis, Hedge Funds, News - Comments
The US Food and Drug Administration (FDA) has recently approved the anti-programmed-death-receptor-1 (anti-PD-1) therapy of Merck & Co., Inc. (NYSE...
Keep Reading →
October 26 - News, Stock Analysis - Comments
Merck & Co., Inc. (NYSE:MRK) will start laying off more than 100 employees in its production plant in Florida next month as it prepares for the closure...
Keep Reading →
October 6 - News, Stock Analysis - Comments
Introduction Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing...
Keep Reading →
August 29 - News, Stock Analysis - Comments
Bourgeon Capital Management LLC, founded by John A. Zaro in 1999, operates as a boutique investment counseling firm that aims to serve high net-worth...
Keep Reading →
August 3 - Hedge Fund Analysis, Hedge Funds, News - Comments
The U.S. dollar is stronger in early Wednesday activity as traders look forward to today’s release of the domestic employment report. With the...
Keep Reading →
August 3 - Earnings Report, Market Movers, News - Comments
U.S. stock futures are flat this morning following a decline in crude prices over worries surrounding renewed oversupply. Investors are also digging into...
Keep Reading →
July 29 - Earnings Report, Market Movers, News - Comments
On July 23, the Food and Drug Administration will make its decision on bezlotoxumab, brand name Zinplava, a Merck & Co., Inc. (NYSE:MRK) monoclonal...
Keep Reading →
July 22 - News, Stock Analysis - Comments
Imagine the following scenario. A patient walks into a hospital with an infectious disease. He sees a physician or a nurse, who diagnoses him, usually...
Keep Reading →
July 19 - News, Stock Analysis - Comments
At the turn of the millennium, the population of the United States clocked in at 282.2 million. By 2030, the US population is expected to be about 362...
Keep Reading →
June 22 - News, Stock Analysis - Comments
All three index futures are in the red in this morning’s pre-market as traders worry about a potential Brexit. While a Brexit wouldn’t be...
Keep Reading →
June 10 - Market Movers, News - Comments
Oil baron and America’s first billionaire John D. Rockefeller once said, ‘do you know the only thing that gives me pleasure? It’s to...
Keep Reading →
May 28 - Dividend Stocks, Hedge Funds, News - Comments
Kahn Brothers Group is a New York-based hedge fund firm founded by Irving Kahn, Thomas Graham Kahn and Alan Kahn in 1978. Irving Kahn, the firm’s founding...
Keep Reading →
May 14 - Hedge Fund Analysis, Hedge Funds, News - Comments
The US Stock market is trading higher on Thursday, helped by a 3% growth in Brent and WTI. Meanwhile, the earnings season is still in progress and among...
Keep Reading →
May 5 - Hedge Funds, News - Comments
HealthInvest Partners is a Stockholm-based fund management company founded by Carl Bennet and Anders Hallberg in 2006. The investment approach employed...
Keep Reading →
April 23 - Hedge Funds, News - Comments
The Kahn Brothers Group, formerly known as Kahn Brothers & Company Inc., was founded in 1978 by renowned investor Irving Kahn, who died last year...
Keep Reading →
February 11 - Hedge Fund Analysis, Hedge Funds, News - Comments
John A. Zaro, a Stanford graduate and a member of the New York Society of Security Analysts, founded Bourgeon Capital in 1999. Michael Keohane joined...
Keep Reading →
November 4 - Hedge Fund Analysis, Hedge Funds, News - Comments